12:38 PM EST - Sona Nanotech Inc : And GE Healthcare Life Sciences will jointly complete test development of the Sona Covid-19 Coronavirus rapid response lateral flow test, and will use GE Healthcare Life Sciences' Fast Flow High Performance Membrane (FFHP) in production of the test. Sona will retain all commercial rights to the resulting test. Sona Nanotech Inc
shares CSE:SONA are trading down $0.27 at $0.67.
